Saturday, July 11, 2026

Drug profile · INN

semustine

semustine is a dna cross-linking agent.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — semustine
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

semustine is a dna cross-linking agent.

Key facts

INN semustine
Mechanism DNA cross-linking agent
Target DNA

Mechanism of action

DNA cross-linking agent

Primary target: DNA

Approval history

Authority Status Date
NMPA clinical trials

Related & competitor drugs

  1. acyclovir Human herpesvirus 1 DNA polymerase inhibitor
  2. acyclovir sodium Human herpesvirus 1 DNA polymerase inhibitor
  3. azacitidine Antineoplastic and immunomodulating agents (L01)
  4. bleomycin sulfate DNA inhibitor
  5. busulfan Antineoplastic and immunomodulating agents (L01)
  6. capecitabine Antineoplastic and immunomodulating agents (L01)

Frequently asked questions

What is semustine?

semustine is a dna cross-linking agent.